Alex Sapir is President and Chief Executive Officer of Fulcrum Therapeutics, Inc. (FULC). The company reported total compensation of $3,251,490 for fiscal year 2025.
| Salary | $650,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $2,052,132 |
| Non-equity incentive plan | $411,200 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $138,158 |
| Total | $3,251,490 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Fulcrum Therapeutics, Inc. filed April 30, 2026, accession 0001193125-26-197196.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $650,000 | $0 | $0 | $2,052,132 | $411,200 | $0 | $138,158 | $3,251,490 |
| FY2024 | President and Chief Executive Officer | $650,000 | $0 | $0 | $0 | $211,300 | $0 | $142,000 | $1,003,300 |
Totals as disclosed in each year's own compensation disclosure for Fulcrum Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Alex Sapir this page | President and Chief Executive Officer | $3,251,490 |
| Alan Musso | Chief Financial Officer | $1,807,125 |
| Curtis Oltmans | Chief Legal Officer and Head of External Affairs | $1,482,850 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Fulcrum Therapeutics, Inc. compensation brief.
Alex Sapir's compensation sits inside Fulcrum Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.